Medical Aesthetic Devices: Technologies and Global Markets
The global market for medical aesthetic devices will experience a 7.4% compound annual growth rate (CAGR) over a 5-year forecast period, with revenues rising from $3.3 billion in 2010 to $4.8 billion in 2015.
SCOPE OF REPORT
This report details the principles of operation, method of manufacture, regulatory restrictions, and current status of the global market for the following medical aesthetic devices:
- Botulinum neuromodulators for aesthetic applications
- Breast augmentation devices, including implants and injectable materials
- Injectable dermal fillers
- Devices for assisted liposuction using ultrasound, light, or water
- Externally-applied energy-emitting devices for:
- Permanent hair removal
- Ablative skin resurfacing
- Non-ablative skin resurfacing
- Treatment of vascular skin lesions
- Skin tightening
- Tattoo removal
- Acne treatment
- Treatment of pigmented skin lesions
- Cellulite reducti
The global market is also segmented geographically into the following regions:
- Rest of the World
Trends in the markets are identified and used in conjunction with past market behavior to forecast future revenues and compounded annual growth rates (CAGRs) in current U.S. dollars from 2010 to 2015.
The regulatory environment for medical devices and drugs in the U.S. and Europe is described in detail, as it exerts a strong effect on the availability of the devices considered in this report. The properties and characteristics of human skin, hair, and breasts are discussed insofar as they affect device demand.
J. Richard Rahn has worked in the medical device industry since 2000 and in the industrial instrumentation industry since 1997. He holds a Ph.D. in optical/ chemical physics. He is the author of several scientific publications and has been awarded eight U.S. patents as well as several foreign patents. He currently has several new patents pending.